New Standards for Administration of Intravascular Contrast Agents for Adults
By MedImaging International staff writers Posted on 04 Mar 2015 |
Revised guidelines to the administration of iodine- and gadolinium-based contrast agents were published.
The update was deemed necessary because of an increase in the use of iodinated and Gadolinium-Based Contrast Agents (GBCA), and new research into potential risks of their use, weighed against potential benefits.
The standards provide guidelines for radiologists and other clinicians, for the prevention and treatment of adverse events related to the use of intravascular contrast agents in adult patients, and were published by the United Kingdom (UK) Royal College of Radiologists (RCR; London, England). The guidelines are intended to improve safety, and care for patients undergoing diagnostic imaging or image-guided interventions.
The main changes documented in the update are the nomenclature and definitions for Contrast-Induced Acute Kidney Injury (CI-AKI). Another change emphasizes the importance of maintaining hydration of patients at risk of CI-AKI, minimizing the dose of intravascular contrast per patient, and taking into account patient factors, the exam indication, and technical scan parameters. In addition, the update mentions the importance of clearer identification of patients at risk, the need for explicit documentation of adverse events when they happen using digital system such as a Radiology Information System (RIS) or Picture Archiving and Communication System (PACS) in case of future imaging exams.
The update is available online and can be downloaded from the website of the RCR.
Related Links:
UK Royal College of Radiologists
The update was deemed necessary because of an increase in the use of iodinated and Gadolinium-Based Contrast Agents (GBCA), and new research into potential risks of their use, weighed against potential benefits.
The standards provide guidelines for radiologists and other clinicians, for the prevention and treatment of adverse events related to the use of intravascular contrast agents in adult patients, and were published by the United Kingdom (UK) Royal College of Radiologists (RCR; London, England). The guidelines are intended to improve safety, and care for patients undergoing diagnostic imaging or image-guided interventions.
The main changes documented in the update are the nomenclature and definitions for Contrast-Induced Acute Kidney Injury (CI-AKI). Another change emphasizes the importance of maintaining hydration of patients at risk of CI-AKI, minimizing the dose of intravascular contrast per patient, and taking into account patient factors, the exam indication, and technical scan parameters. In addition, the update mentions the importance of clearer identification of patients at risk, the need for explicit documentation of adverse events when they happen using digital system such as a Radiology Information System (RIS) or Picture Archiving and Communication System (PACS) in case of future imaging exams.
The update is available online and can be downloaded from the website of the RCR.
Related Links:
UK Royal College of Radiologists
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment